Endocrinology, Vol 132, 2507-2512, Copyright © 1993 by Endocrine Society

ARTICLES

Rat ovarian insulin-like growth factor-binding protein-6: a hormonally regulated theca-interstitial-selective species with limited antigonadotropic activity

RM Rohan, E Ricciarelli, MC Kiefer, CE Resnick and EY Adashi
Department of Obstetrics/Gynecology and Physiology, University of Maryland School of Medicine, Baltimore 21201.

Most but not all of the established insulin-like growth factor-binding proteins (IGFBPs) are expressed in the rat ovary. To continue the process of characterizing these ovarian IGFBPs, a solution hybridization/RNase protection assay was used to study IGFBP-6 gene expression, cellular localization, and hormonal regulation in the immature rat ovary. Total RNA was hybridized with a 458-base long 32P- labeled rat IGFBP-6 cRNA. A single protected fragment (380 bases long) corresponding to IGFBP-6 transcripts was identified in RNA from ovary and lung, but not kidney or liver. The amount of IGFBP-6 transcripts was higher in ovaries from immature rats (25-28 days old) than in ovaries from adult rats and was higher in theca-interstitial than in granulosa cell preparations. Hypophysectomy resulted in a significant (P < 0.05) 2.3 +/- 0.7-fold (mean +/- SD) increase in whole ovarian IGFBP-6 transcripts. This suggests that ovarian IGFBP-6 gene expression is subject to inhibition by one or more pituitary hormones. Therefore, the effect of replacement of FSH, GH, diethylstilbestrol (DES), or combinations thereof was evaluated. Treatment with FSH resulted in a 2.4-fold decrease (P < 0.05) in the abundance of ovarian IGFBP-6 transcripts relative to that in hypophysectomized controls. Provision of DES yielded comparable results. Moreover, the combined provision of FSH and DES resulted in a synergistic decrease (6.0-fold) in ovarian IGFBP-6 transcripts. In contrast, treatment of hypophysectomized rats with GH proved without effect. However, treatment with FSH or DES in addition to GH resulted in a decrease in ovarian IGFBP-6 transcripts (3.9- and 2.7-fold, respectively). To assess the role of ovarian IGFBP- 6, its influence on gonadotropin action in primary cultures of rat granulosa cells was also studied. Increasing concentrations (0.01-1 micrograms/ml) of recombinantly expressed human IGFBP-6 did not inhibit the FSH-supported accumulation of either progesterone or estradiol. These findings 1) establish the theca-interstitial compartment of the immature rat ovary as a prominent site of IGFBP-6 gene expression, 2) implicate FSH and DES as inhibitors of IGFBP-6 transcript levels in the whole ovary, 3) and disclose the limited antigonadotropic action of IGBP-6F on the rat granulosa cell.

This article has been cited by other articles:

				M. Paciga, A. J. Watson, G. E. DiMattia, and G. F. Wagner Ovarian Stanniocalcin Is Structurally Unique in Mammals and Its Production and Release Are Regulated through the Luteinizing Hormone Receptor Endocrinology, October 1, 2002; 143(10): 3925 - 3934. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				S.-A. Wandji, T. L. Wood, J. Crawford, S. W. Levison, and J. M. Hammond Expression of Mouse Ovarian Insulin Growth Factor System Components During Follicular Development and Atresia Endocrinology, December 1, 1998; 139(12): 5205 - 5214. [Abstract] [Full Text] [PDF]

				C. E. Resnick, P. J. Fielder, R. G. Rosenfeld, and E. Y. Adashi Characterization and Hormonal Regulation of a Rat Ovarian Insulin-Like Growth Factor Binding Protein-5 Endopeptidase: An FSH-Inducible Granulosa Cell-Derived Metalloprotease Endocrinology, March 1, 1998; 139(3): 1249 - 1257. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				E. Y. Adashi, C. E. Resnick, D. W. Payne, R. G. Rosenfeld, T. Matsumoto, M. K. Hunter, S. E. Gargosky, J. Zhou, and C. A. Bondy The Mouse Intraovarian Insulin-Like Growth Factor I System: Departures from the Rat Paradigm Endocrinology, September 1, 1997; 138(9): 3881 - 3890. [Abstract] [Full Text] [PDF]

				L. Putowski, R. M. Rohan, D. S. Choi, W. J. Scherzer, E. Ricciarelli, J. Mordacq, K. E. Mayo, and E. Y. Adashi Rat Ovarian Insulin-Like Growth Factor Binding Protein-4: A Hormone-Dependent Granulosa Cell-Derived Antigonadotropin Reproductive Sciences, May 1, 1997; 4(3): 144 - 151. [Abstract] [PDF]

				W. J. Scherzer, K. S. L. Ruutiainen-Altman, L. T. Putowski, S. Kol, E. Y. Adashi, and R. M. Rohan Detection and In Vivo Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-I Rececptor mRNAs: Increased Expression During the Periovulatory Period Reproductive Sciences, May 1, 1996; 3(3): 131 - 139. [Abstract] [PDF]

				E. Y. Adashi Insulin-Like Growth Factors as Determinants of Follicular Fate Reproductive Sciences, November 1, 1995; 2(6): 721 - 726. [Abstract] [PDF]

				L. T. Putowski, D. Choi, J. Mordacq, W. J. Scherzer, K. E. Mayo, E. Y. Adashi, and R. M. Rohan In vivo Hormonal Regulation of Insulin-Like Growth Factor Binding Protein-5 mRNA in the Immature Rat Ovary Reproductive Sciences, November 1, 1995; 2(6): 735 - 742. [Abstract] [PDF]